Homocysteine and atherothrombosis

被引:22
作者
Falk, E
Zhou, J
Moller, J
机构
[1] Aarhus Univ Hosp Skejby, Dept Cardiol, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp Skejby, Dept Clin Biochem, DK-8200 Aarhus N, Denmark
关键词
D O I
10.1007/s11745-001-0676-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atherosclerosis with or without thrombosis superimposed is the most frequent cause of ischemic heart disease (IHD), peripheral arterial disease, and a main cause of stroke. Conflicting results have been reported in genetic, observational, and experimental studies on the relationship between homocysteine and these atherothrombotic diseases. Although cardiovascular complications are common in homocystinuric patients (severe hyperhomocysteinemia), IHD, the most frequent manifestation of atherothrombosis in the general population, appears to be rare. On the basis of findings in individuals with hyperhomocysteinemia of genetic origin, there is in fact no clear evidence for a causal role of homocysteine in the pathogenesis of atherothrombotic disease, and the positive association between plasma homocysteine and IHD observed in many, but not all epidemiologic studies does not prove causality. To infer causality from observational studies, there should be a temporal, consistent, strong, independent, graded (dose-response effect), and duration-dependent relationship between exposure and outcomes, and a biologically plausible mechanism should exist. The relationship between plasma homocysteine levels and IHD does not fulfill these criteria beyond reasonable doubt. In the general population, plasma homocysteine levels are to a great extent determined by dietary habits, and plasma homocysteine could be a marker, or a consequence, of atherothrombosis and/or risk-associated behavior (e.g., a diet low in fruits and vegetables) rather than a cause of atherothrombosis. Experimentally, hyperhomocysteinemia is not in itself atherogenic in normal animals with relatively low plasma cholesterol levels. The homocysteine theory of atherosclerosis should be tested more thoroughly in hypercholesterolemic animals that develop atherosclerosis spontaneously to determine whether elevated plasma homocysteine levels are harmful under atherogenic conditions. A causal role of homocysteine in atherothrombotic disease remains to be established.
引用
收藏
页码:S3 / S11
页数:9
相关论文
共 90 条
[1]   Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease [J].
Anderson, JL ;
Muhlestein, JB ;
Horne, BD ;
Carlquist, JF ;
Bair, TL ;
Madsen, TE ;
Pearson, RR .
CIRCULATION, 2000, 102 (11) :1227-1232
[2]  
BENAVENTE O, 1998, CARDIOVASCULAR THROM
[3]   HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[4]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[5]  
Brattström L, 2000, AM J CLIN NUTR, V72, P315
[6]   Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease -: The result of a meta-analysis [J].
Brattström, L ;
Wilcken, DEL ;
Öhrvik, J ;
Brudin, L .
CIRCULATION, 1998, 98 (23) :2520-2526
[7]  
*CAS REC MASS GEN, 1933, NEW ENGL J MED, V209, P1063
[8]  
Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165
[9]   IMPAIRED ENDOTHELIAL FUNCTION OCCURS IN THE SYSTEMIC ARTERIES OF CHILDREN WITH HOMOZYGOUS HOMOCYSTINURIA BUT NOT IN THEIR HETEROZYGOUS PARENTS [J].
CELERMAJER, DS ;
SORENSEN, K ;
RYALLS, M ;
ROBINSON, J ;
THOMAS, O ;
LEONARD, JV ;
DEANFIELD, JE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (03) :854-858
[10]   Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects [J].
Chambers, JC ;
Obeid, OA ;
Kooner, JS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2922-2927